Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Jennifer S. Temel"'
Autor:
Justin F. Gainor, Alexander Drilon, Aaron N. Hata, Sai-Hong Ignatius Ou, Michael S. Lawrence, Alice T. Shaw, Jochen K. Lennerz, Beow Y. Yeap, Lecia V. Sequist, Jennifer S. Temel, Christina J. Falcon, Adam J. Schoenfeld, Adam Langenbucher, Harper G. Hubbeling, Wafa Malik, Kylie Prutisto-Chang, Jennifer Peterson, Andrew Do, Charlotte Lee, Subba R. Digumarthy, Ibiayi Dagogo-Jack, Ramin Sakhtemani, Ted W. Johnson, Viola W. Zhu, Satoshi Yoda, Noura J. Choudhury, Jessica J. Lin
Supplementary Tables 1-2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e5b19d00684fec600f7f9f19f325d89
https://doi.org/10.1158/1078-0432.22478825
https://doi.org/10.1158/1078-0432.22478825
Autor:
Justin F. Gainor, Alexander Drilon, Aaron N. Hata, Sai-Hong Ignatius Ou, Michael S. Lawrence, Alice T. Shaw, Jochen K. Lennerz, Beow Y. Yeap, Lecia V. Sequist, Jennifer S. Temel, Christina J. Falcon, Adam J. Schoenfeld, Adam Langenbucher, Harper G. Hubbeling, Wafa Malik, Kylie Prutisto-Chang, Jennifer Peterson, Andrew Do, Charlotte Lee, Subba R. Digumarthy, Ibiayi Dagogo-Jack, Ramin Sakhtemani, Ted W. Johnson, Viola W. Zhu, Satoshi Yoda, Noura J. Choudhury, Jessica J. Lin
Supplementary Figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb9ca50fde65b62aaec84f5f254dafcb
https://doi.org/10.1158/1078-0432.22478831.v1
https://doi.org/10.1158/1078-0432.22478831.v1
Autor:
Justin F. Gainor, Alexander Drilon, Aaron N. Hata, Sai-Hong Ignatius Ou, Michael S. Lawrence, Alice T. Shaw, Jochen K. Lennerz, Beow Y. Yeap, Lecia V. Sequist, Jennifer S. Temel, Christina J. Falcon, Adam J. Schoenfeld, Adam Langenbucher, Harper G. Hubbeling, Wafa Malik, Kylie Prutisto-Chang, Jennifer Peterson, Andrew Do, Charlotte Lee, Subba R. Digumarthy, Ibiayi Dagogo-Jack, Ramin Sakhtemani, Ted W. Johnson, Viola W. Zhu, Satoshi Yoda, Noura J. Choudhury, Jessica J. Lin
Supplementary methods, figure legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47e82d757e4978f6be4f2a06e2e25469
https://doi.org/10.1158/1078-0432.22478828
https://doi.org/10.1158/1078-0432.22478828
Autor:
Justin F. Gainor, Alexander Drilon, Aaron N. Hata, Sai-Hong Ignatius Ou, Michael S. Lawrence, Alice T. Shaw, Jochen K. Lennerz, Beow Y. Yeap, Lecia V. Sequist, Jennifer S. Temel, Christina J. Falcon, Adam J. Schoenfeld, Adam Langenbucher, Harper G. Hubbeling, Wafa Malik, Kylie Prutisto-Chang, Jennifer Peterson, Andrew Do, Charlotte Lee, Subba R. Digumarthy, Ibiayi Dagogo-Jack, Ramin Sakhtemani, Ted W. Johnson, Viola W. Zhu, Satoshi Yoda, Noura J. Choudhury, Jessica J. Lin
Purpose:Current standard initial therapy for advanced, ROS proto-oncogene 1, receptor tyrosine kinase fusion (ROS1)-positive (ROS1+) non–small cell lung cancer (NSCLC) is crizotinib or entrectinib. Lorlatinib, a next-generation anaplastic lymphoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5172c89aba121b65d81b64c96d23e465
https://doi.org/10.1158/1078-0432.c.6530057.v1
https://doi.org/10.1158/1078-0432.c.6530057.v1
Autor:
Satoshi Yoda, Wafa Malik, Adam Langenbucher, Justin F. Gainor, Sai-Hong Ignatius Ou, Kylie Prutisto-Chang, Ramin Sakhtemani, Jennifer L Peterson, Aaron N. Hata, Alexander Drilon, Andrew Do, Jessica J. Lin, Adam J. Schoenfeld, Viola W. Zhu, Ted William Johnson, Jochen K. Lennerz, Lecia V. Sequist, Noura J. Choudhury, Ibiayi Dagogo-Jack, Subba R. Digumarthy, Christina Falcon, Charlotte E. Lee, Alice T. Shaw, Michael S. Lawrence, Beow Y. Yeap, Jennifer S. Temel, Harper Hubbeling
Publikováno v:
Clin Cancer Res
Purpose: Current standard initial therapy for advanced, ROS proto-oncogene 1, receptor tyrosine kinase fusion (ROS1)-positive (ROS1+) non–small cell lung cancer (NSCLC) is crizotinib or entrectinib. Lorlatinib, a next-generation anaplastic lymphoma
Autor:
Ryan D. Nipp, Jennifer S. Temel
Publikováno v:
Clinical Cancer Research. 24:1777-1779
Patient-reported outcomes (PRO) represent an increasingly important mechanism for incorporating patients' experiences and perspectives into their care to enhance cancer care delivery and outcomes. In this article, we discuss the importance of integra
Autor:
Areej El-Jawahri, Jennifer A. Shin, Jennifer S. Temel, Lara Traeger, Amanda Parkes, Helen P. Knight, Stephen M. Schleicher
Publikováno v:
Cancer Research. 75:P5-15
Background: Data suggest that patients with metastatic cancer who understand their prognosis are more likely to prefer and receive care concordant with their wishes. Despite the importance of prognostic information for patients’ decision-making, th
Autor:
Areej El-Jawahri, Lara Traeger, Helen P. Knight, Amanda Parkes, Jennifer A. Shin, Jennifer S. Temel
Publikováno v:
Cancer Research. 75:P5-16
Background: Hospitalizations in patients with metastatic cancer occur commonly at the end of life but have not been well-described in those with metastatic breast cancer (MBC). The goal of this study was to describe the reasons for admission, end-of-
Autor:
Frances A. Shepherd, David C. Christiani, Panos Fidias, Geoffrey Liu, John C. Wain, Rebecca S. Heist, Wei Zhou, Ariela L. Marshall, Li Su, David P. Miller, Penelope A. Bradbury, Sohee Park, Lecia V. Sequist, Matthew H. Kulke, Jennifer S. Temel, Thomas J. Lynch
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 17:204-211
Purpose: Case-control and observational studies are popular choices for evaluating molecular prognostic/pharmacogenetic outcomes, but data quality is rarely tested. Using clinical trial and epidemiologic methods, we assessed the quality of prognostic